Gene expression in eukaryotic and prokaryotic cells is tightly controlled to ensure that each cell type produces only the proteins necessary for its function. Regulation occurs primarily at the transcriptional level, involving promoter regions, enhancers, silencers, and epigenetic modifications.
Promoter Region
| Feature | Description |
|---|---|
| Location | Upstream from the gene locus |
| Key Elements | TATA box (binding site for RNA polymerase II initiation),
CAAT box (regulates frequency of transcription) |
| Function | The site where RNA polymerase II and transcription factors bind to start transcription |
| Clinical Correlation | Promoter mutations → ↓ transcription levels → ↓ protein synthesis (e.g., certain β-thalassemias due to decreased β-globin transcription) |
Key Point:
Promoter integrity is essential for proper transcription initiation; mutations can drastically reduce gene expression.
Enhancers and Silencers
| Feature | Enhancer | Silencer |
|---|---|---|
| Definition | DNA sequence where activator proteins bind to increase gene expression | DNA sequence where repressor proteins bind to decrease gene expression |
| Location | Can be close, far, or within (intron) the regulated gene | It can also be variable in location relative to the gene |
| Mechanism | Enhancer-bound proteins interact with transcription machinery at the promoter through DNA looping | Repressors inhibit transcription factor binding or block RNA polymerase |
Key Point:
Enhancers and silencers regulate how much gene product is made — not the coding sequence itself.
Epigenetic Regulation
Epigenetics refers to heritable changes in gene expression that occur without altering the DNA sequence.
| Mechanism | Effect on Gene Expression | Notes / Examples |
|---|---|---|
| DNA Methylation | ↓ Gene transcription (silencing) | Methylation of CpG islands represses transcription; critical for X-inactivation and genomic imprinting |
| Histone Acetylation | ↑ Transcription | Opens chromatin (euchromatin formation) |
| Histone Deacetylation | ↓ Transcription | Condenses chromatin (heterochromatin) |
| Noncoding RNA | Post-transcriptional gene silencing | miRNA binds mRNA → degradation or translation inhibition |
Clinical Tie-In:
- Cancer cells often show global hypomethylation (activation of oncogenes) or hypermethylation of tumor suppressor genes.
- Fragile X syndrome involves methylation-induced silencing of the FMR1 gene.
Learning Objective
After completing this topic, students should be able to: Explain how promoters, enhancers, silencers, and epigenetic mechanisms regulate gene expression and identify clinical outcomes associated with their dysfunction.
